Results 1 - 20 of 615 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Show only
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Web Resources
|
|
Benzinga: Cytokinetics Shares Gain On Positive Data From Heart Disease CandidateNewstex Finance & Accounting Blogs, 2021Copyright Newstex Jul 19, 2021Digital Resources/Online E-Resources |
| 2 |
Material Type: Web Resources
|
|
Benzinga: FDA Accepts Bristol-Myers' Mavacamten Application In Inherited Heart Disease For ReviewNewstex Finance & Accounting Blogs, 2021Copyright Newstex Mar 19, 2021Digital Resources/Online E-Resources |
| 3 |
Material Type: Web Resources
|
|
Assessment of left atrial function in feline hypertrophic cardiomyopathy by using two- dimensional speckle tracking echocardiographyBMC Veterinary Research, 20202020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.21203/rs.3.rs-17226/v4Digital Resources/Online E-Resources |
| 4 |
Material Type: Web Resources
|
|
Benzinga: Alnylam Shares Detailed Patisiran Data From Rare Disease StudyNewstex Finance & Accounting Blogs, 2022Copyright Newstex Sep 8, 2022Digital Resources/Online E-Resources |
| 5 |
Material Type: Web Resources
|
|
Zacks Investment Research: BridgeBio (BBIO) Tumbles on Cardiomyopathy Candidate FailureNewstex Finance & Accounting Blogs, 2021Copyright Newstex Dec 28, 2021Digital Resources/Online E-Resources |
| 6 |
Material Type: Web Resources
|
|
Benzinga: Five-Year Follow-Up Data Show Pfizer's Tafamidis Cuts Risk of Mortality by 41% In Cardiomyopathy PatientsNewstex Finance & Accounting Blogs, 2021Copyright Newstex Dec 21, 2021Digital Resources/Online E-Resources |
| 7 |
Material Type: Web Resources
|
|
Benzinga: Bristol Myers Unveils More Mavacamten Data To Backup Case For Heart DrugNewstex Finance & Accounting Blogs, 2021Copyright Newstex May 17, 2021Digital Resources/Online E-Resources |
| 8 |
Material Type: Web Resources
|
|
Benzinga: Cytokinetics' Heart Drug Is A Multi-Billion Dollar Opportunity By 2032 Despite Novartis Setback: AnalystNewstex Finance & Accounting Blogs, 2024Copyright Newstex Jan 12, 2024Digital Resources/Online E-Resources |
| 9 |
Material Type: Web Resources
|
|
NJ Spotlight - WNET Spotlight LLC: Pallones fight against sudden cardiac arrest in kidsNJ Spotlight News, 2023Copyright Newstex Dec 19, 2023Digital Resources/Online E-Resources |
| 10 |
Material Type: Web Resources
|
|
Genetic Determinants of Clinical Phenotype in Hypertrophic CardiomyopathyBMC Cardiovascular Disorders, 20202020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.21203/rs.3.rs-36810/v5Digital Resources/Online E-Resources |
| 11 |
Material Type: Web Resources
|
|
24/7 Wall St.: Could Applied Therapeutics Stock Rise 300%?Newstex Finance & Accounting Blogs, 2020Copyright Newstex Oct 8, 2020Digital Resources/Online E-Resources |
| 12 |
Material Type: Web Resources
|
|
PharmaTimes: First treatment for ‘broken heart syndrome’ trialledPharmaTimes, 2022Copyright Newstex Jun 29, 2022Digital Resources/Online E-Resources |
| 13 |
Material Type: Web Resources
|
|
Benzinga: Alnylam Reinforces Patisiran Data In Stiff Heart Disorder Before Heading For FDA ApprovalNewstex Finance & Accounting Blogs, 2022Copyright Newstex Oct 3, 2022Digital Resources/Online E-Resources |
| 14 |
Material Type: Web Resources
|
|
Benzinga: Sangamo's Fabry Disease Gene Therapy Continues To Show Encouraging Safety ProfileNewstex Finance & Accounting Blogs, 2022Copyright Newstex Aug 30, 2022Digital Resources/Online E-Resources |
| 15 |
Material Type: Web Resources
|
|
Trefis: Is Alnylam Stock Poised For More Gains After A Stellar 50% Rise In A Month?Newstex Finance & Accounting Blogs, 2022Copyright Newstex Aug 22, 2022Digital Resources/Online E-Resources |
| 16 |
Material Type: Web Resources
|
|
PharmaTimes: NICE rejects Pfizer’s rare heart disease treatment VyndaqelPharmaTimes, 2021Copyright Newstex May 12, 2021Digital Resources/Online E-Resources |
| 17 |
Material Type: Web Resources
|
|
Newsfile Corp.: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. - ALNYNewstex Finance & Accounting Blogs, 2023Copyright Newstex Nov 30, 2023Digital Resources/Online E-Resources |
| 18 |
Material Type: Web Resources
|
|
Newsfile Corp.: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. - ALNYNewstex Finance & Accounting Blogs, 2023Copyright Newstex Nov 17, 2023Digital Resources/Online E-Resources |
| 19 |
Material Type: Web Resources
|
|
Newsfile Corp.: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. - ALNYNewstex Finance & Accounting Blogs, 2023Copyright Newstex Nov 9, 2023Digital Resources/Online E-Resources |
| 20 |
Material Type: Web Resources
|
|
Newsfile Corp.: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. - ALNYNewstex Finance & Accounting Blogs, 2023Copyright Newstex Nov 1, 2023Digital Resources/Online E-Resources |
Results 1 - 20 of 615 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Show only
Refine My Results
Creation Date
- Before 2019 (1)
- 2019 To 2019 (62)
- 2020 To 2020 (121)
- 2021 To 2022 (147)
- After 2022 (285)
-
More options
New Records
Subject
- Cardiomyopathy (601)
- Earnings Per Share (284)
- Gene Therapy (275)
- Institutional Investments (249)
- Clinical Trials (168)
- Ischemia (117)
- Stock Prices (115)
- Hedge Funds (107)
- Stem Cells (107)
- Heart Failure (90)
- Corporate Profits (82)
- Covid-19 (79)
- Ratings & Rankings (78)
- Pandemics (74)
- Valuation (71)
- Coronaviruses (68)
- Investments (67)
- Stocks (58)
- Litigation (57)
- Biotechnology Industry (46)
-
More options
Databases
- ProQuest Central (598)
- ProQuest One Psychology (5)
- Cambridge University Library IR - DSpace@Cambridge (3)
- DOAJ Directory of Open Access Journals (2)
- ROAD: Directory of Open Access Scholarly Resources (1)
- Diposit Digital de la Universitat de Barcelona (1)
- Iowa State Digital Repository (1)
- Geneva Foundation Free Medical Journals at publisher websites (1)
- Open Access: PubMed Central (1)
-
More options
Language
- English (609)
- French (6)
- Croatian (2)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||